The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis
Open accessAbstract
BACKGROUND: Coronavirus disease 2019 (COVID-19) is an evolving infectious disease that dramatically spread all over the world in the early part of 2020. No studies have yet summarized the potential severity and mortality risks caused by COVID-19 in patients with chronic obstructive pulmonary disease (COPD), and we update information in smokers. METHODS: We systematically searched electronic databases from inception to March 24, 2020. Data were extracted by two independent authors in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Study quality was assessed using a modified version of the Newcastle-Ottawa Scale. We synthesized a narrative from eligible studies and conducted a meta-analysis using a random-effects model to calculate pooled prevalence rates and 95% confidence intervals (95%CI). RESULTS: In total, 123 abstracts were screened and 61 full-text manuscripts were reviewed. A total of 15 studies met the inclusion criteria, which included a total of 2473 confirmed COVID-19 patients. All studies were included in the meta-analysis. The crude case fatality rate of COVID-19 was 7.4%. The pooled prevalence rates of COPD patients and smokers in COVID-19 cases were 2% (95% CI, 1%-3%) and 9% (95% CI, 4%-14%) respectively. COPD patients were at a higher risk of more severe disease (risk of severity = 63%, (22/35) compared to patients without COPD 33.4% (409/1224) [calculated RR, 1.88 (95% CI, 1.4-2.4)]. This was associated with higher mortality (60%). Our results showed that 22% (31/139) of current smokers and 46% (13/28) of ex-smokers had severe complications. The calculated RR showed that current smokers were 1.45 times more likely [95% CI: 1.03-2.04] to have severe complications compared to former and never smokers. Current smokers also had a higher mortality rate of 38.5%. CONCLUSION: Although COPD prevalence in COVID-19 cases was low in current reports, COVID-19 infection was associated with substantial severity and mortality rates in COPD. Compared to former and never smokers, current smokers were at greater risk of severe complications and higher mortality rate. Effective preventive measures are required to reduce COVID-19 risk in COPD patients and current smokers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
(2014) · Medical Entomology and Zoology · Cited by 17,633
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis
Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00547-2020 · Cited by 3,680
Virtually perfect? Telemedicine for COVID-19
Hollander, J. E., & Carr, B. G. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2003539 · Cited by 2,970
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.03.003 · Cited by 2,948
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101623 · Cited by 2,542
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259
Xu, X.-W., Wu, X.-X., Jiang, X.-G., Xu, K.-J., Ying, L.-J., Ma, C.-L., Li, S.-B., Wang, H.-Y., Zhang, S., Gao, H.-N., et al. (2020) · BMJ · doi:10.1136/bmj.m606 · Cited by 2,046
Grasselli, G., Pesenti, A., & Cecconi, M. (2020) · JAMA · doi:10.1001/jama.2020.4031 · Cited by 2,023
Characteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State
Eastin, C., & Eastin, T. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.04.002 · Cited by 1,869
Peeri, N. C., Shrestha, N., Rahman, M. S., Zaki, R., Tan, Z., Bibi, S., Baghbanzadeh, M., Aghamohammadi, N., Zhang, W., & Haque, U. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa033 · Cited by 1,610 · cited 1×
“Although the symptoms and clinical presentation of COVID-19 is similar to SARS and MERS, the rate of spread is greater [5].”
BackgroundGlobal burden of COPD: systematic review and meta-analysis
Halbert, R. J., Natoli, J. L., Gano, A., Badamgarav, E., Buist, A. S., & Mannino, D. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00124605 · Cited by 1,499
Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia
Zhu, H., Wang, L., Fang, C., Peng, S., Zhang, L., Chang, G., Xia, S., & Zhou, W. (2020) · Translational Pediatrics · doi:10.21037/tp.2020.02.06 · Cited by 1,426
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
Liu, K., Fang, Y.-Y., Deng, Y., Liu, W., Wang, M.-F., Ma, J.-P., Xiao, W., Wang, Y.-N., Zhong, M.-H., Li, C.-H., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000744 · Cited by 1,411
COVID-19 and smoking: A systematic review of the evidence
Vardavas, C., & Nikitara, K. (2020) · Tobacco Induced Diseases · doi:10.18332/tid/119324 · Cited by 1,380
COPD exacerbations: Defining their cause and prevention
Wedzicha, J. A., & Seemungal, T. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61382-8 · Cited by 1,370
Clinical Characteristics of Coronavirus Disease 2019 in China
Eastin, C., & Eastin, T. (2020) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.04.004 · Cited by 1,234
Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., & Johnston, S. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-859oc · Cited by 1,072 · cited 1×
“Various factors have been described to contribute to acute worsening of COPD, however, viral infection remains the main trigger, including seasonal coronaviruses (12-14).”
BackgroundMortality in COPD: role of comorbidities
Sin, D. D., Anthonisen, N. R., Soriano, J. B., & Agusti, A. G. (2006) · European Respiratory Journal · doi:10.1183/09031936.00133805 · Cited by 1,052
Facing Covid-19 in Italy — Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line
Rosenbaum, L. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2005492 · Cited by 881
Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China
Mo, P., Xing, Y., Xiao, Y., Deng, L., Zhao, Q., Wang, H., Xiong, Y., Cheng, Z., Gao, S., Liang, K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa270 · Cited by 853
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2
Xu, X., Yu, C., Qu, J., Zhang, L., Jiang, S., Huang, D., Chen, B., Zhang, Z., Guan, W., Ling, Z., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04735-9 · Cited by 788
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China
Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y., Li, J., Peng, Z., & Pan, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104364 · Cited by 694
Clinical characteristics of 82 cases of death from COVID-19
Zhang, B., Zhou, X., Qiu, Y., Song, Y., Feng, F., Feng, J., Song, Q., Jia, Q., & Wang, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0235458 · Cited by 683
Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities
Miravitlles, M., Soriano, J. B., Garcia-Rio, F., Munoz, L., Duran-Tauleria, E., Sanchez, G., Sobradillo, V, & Ancochea, J. (2009) · Thorax · doi:10.1136/thx.2009.115725 · Cited by 640
Wu, J., Wu, X., Zeng, W., Guo, D., Fang, Z., Chen, L., Huang, H., & Li, C. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000670 · Cited by 629
Sex difference and smoking predisposition in patients with COVID-19
Cai, H. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30117-x · Cited by 625
Cardiovascular comorbidity and its impact on patients with COVID-19
Guan, W.-J., Liang, W.-H., He, J.-X., & Zhong, N.-S. (2020) · European Respiratory Journal · doi:10.1183/13993003.01227-2020 · Cited by 618
Chronic obstructive pulmonary disease in China: a nationwide prevalence study
Fang, L., Gao, P., Bao, H., Tang, X., Wang, B., Feng, Y., Cong, S., Juan, J., Fan, J., Lu, K., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30103-6 · Cited by 467
Li, X., Wang, L., Yan, S., Yang, F., Xiang, L., Zhu, J., Shen, B., & Gong, Z. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.053 · Cited by 402
Wang, M., Luo, X., Xu, S., Liu, W., Ding, F., Zhang, X., Wang, L., Liu, J., Hu, J., & Wang, W. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30432-6 · Cited by 326
Eastin, C., & Eastin, T. (2020) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.04.007 · Cited by 263
White, A. J. (2003) · Thorax · doi:10.1136/thorax.58.1.73 · Cited by 252
Huang, Y., Tu, M., Wang, S., Chen, S., Zhou, W., Chen, D., Zhou, L., Wang, M., Zhao, Y., Zeng, W., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101606 · Cited by 229
Hurst, J. R., Skolnik, N., Hansen, G. J., Anzueto, A., Donaldson, G. C., Dransfield, M. T., & Varghese, P. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.12.014 · Cited by 222
Self-citationOn the front lines of coronavirus: the Italian response to covid-19
Paterlini, M. (2020) · BMJ · doi:10.1136/bmj.m1065 · Cited by 192
Zhu, W., Xie, K., Lu, H., Xu, L., Zhou, S., & Fang, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25763 · Cited by 180
Time course and pattern of COPD exacerbation onset
Aaron, S. D., Donaldson, G. C., Whitmore, G. A., Hurst, J. R., Ramsay, T., & Wedzicha, J. A. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200768 · Cited by 179
Self-citationClinical characteristics of 36 non-survivors with COVID-19 in Wuhan, ChinaPreprint
Huang, Y., Yang, R., Xü, Y., & Gong, P. (2020) · medRxiv · doi:10.1101/2020.02.27.20029009 · Cited by 131
Clinical characteristics of 101 COVID-19 nonsurvivors in Wuhan, China: a retrospective studyPreprint
Shi, Q., Zhao, K., Yu, J., Jiang, F., Feng, J., Zhao, K., Zhang, X., Chen, X., Hu, P., Hong, Y.-P., et al. (2020) · medRxiv · doi:10.1101/2020.03.04.20031039 · Cited by 50
Nutritional supplementation during pulmonary rehabilitation in COPD: A systematic review
Aldhahir, A. M., Rajeh, A. M. A., Aldabayan, Y. S., Drammeh, S., Subbu, V., Alqahtani, J. S., Hurst, J. R., & Mandal, S. (2020) · Chronic Respiratory Disease · doi:10.1177/1479973120904953 · Cited by 44
Self-citationImpact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD
on behalf of the AERIS Study Group, Williams, N. P., Ostridge, K., Devaster, J., Kim, V., Coombs, N. A., Bourne, S. C., Clarke, S. C., Harden, S. P., Abbas, A., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0842-8 · Cited by 36
de Ramón-Fernández, A., Fernández, D. R., Marcos-Jorquera, D., & Gilart-Iglesias, V. (2020) · Journal of Medical Internet Research · doi:10.2196/17161 · Cited by 20
Global use, utility, and methods of tele-health in COPD: a health care provider survey
Rajeh, A. M. A., Aldabayan, Y. S., Aldhahir, A. M., Pickett, E., Quaderi, S. A., Alqahtani, J. S., Lipman, M. C. I., & Hurst, J. R. (2019) · International Journal of COPD · doi:10.2147/copd.s202640 · Cited by 15
Self-citationNutritional Supplementation during Pulmonary Rehabilitation in COPD: A Systematic ReviewPreprint
Aldhahir, A. M., Rajah, A. M. A., Aldabayan, Y. S., Drammeh, S., Subbu, V., Alqahtani, J. S., Hurst, J. R., & Mandal, S. (2019) · medRxiv · doi:10.1101/19000786 · Cited by 6
Self-citation
Cited by
Chronic obstructive pulmonary disease
Christenson, S. A., Smith, B. M., Bafadhel, M., & Putcha, N. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00470-6 · Cited by 1,219
Beyerstedt, S., Casaro, E. B., & Rangel, É. B. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04138-6 · Cited by 897
Dessie, Z. G., & Zewotir, T. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06536-3 · Cited by 875
Halpin, D. M. G., Criner, G. J., Papi, A., Singh, D., Anzueto, A., Martinez, F. J., Agusti, A. A., & Vogelmeier, C. F. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3533so · Cited by 760
The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis
Reddy, R. K., Charles, W. N., Sklavounos, A., Dutt, A., Seed, P. T., & Khajuria, A. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26389 · Cited by 458
Metadata
- Authors
- Alqahtani, J. S., Oyelade, T., Aldhahir, A. M., Alghamdi, S. M., Almehmadi, M., Alqahtani, A. S., Quaderi, S., Mandal, S., & Hurst, J. R.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-05-11
- Volume
- 15
- Issue
- 5
- Pages
- e0233147
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W3021329327
- Cited by
- 858
- References
- 56
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.